Hyderabad-based
Dr Reddy's
has entered into exclusive distribution
partnership
with Sanofi Healthcare India for the MNC’s vaccine brands in India. The domestic company will promote and distribute Sanofi’s vaccine brands including well-established paediatric and adult
vaccines
in India including
Hexaxim
,
Pentaxim
,
Menactra
and FluQuadri, says a company statement.
These brands saw combined sales of approx. Rs 426 crore as per IQVIA (MAT February 2024). The partnership gives Dr Reddy’s a strong portfolio and major presence in the vaccine segment taking it to second position among vaccine players in the country.
Preeti Futnani
, GM India for vaccines, Sanofi, said, “To fulfil our long-term commitment to India and expand our geographic reach, we’re pleased to partner with Dr Reddy’s for exclusive
distribution
and promotion.”